In the present study, we used dietary Pi supplementation and the osteocyte-specific deletion of Fgf23 to correct hypophosphatemia in order to study the respective contributions of FGF23 excess, hypophosphatemia, and DMP1 deficiency to the bone defects in adult Dmp1-null mice. This evidence concerns the gene FGF23 and hypophosphatemia.